Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
VETAPHARMA BELGIUM from Charleroi, company number BE0799278713, closed financial year 2025 with a result of € -161,631 after tax. For that financial year VETAPHARMA BELGIUM recorded a gross margin of € -1,054 and equity of € -166,255. Compared with financial year 2024, the result moved from € -14,624 to € -161,631. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 12, 2026.
€ -166,255
▼ € 161,631 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -161,631
▼ 1005 % more loss than in 2024
Profit after tax over the fiscal year.
€ 12,432
▲ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -176,255.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,815
▼ 64% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -14,070 | € -1,054 | ▲ € 13,016 |
| Profit after taxes | € -14,624 | € -161,631 | ▼ € 147,007 |
| Equity | € -4,624 | € -166,255 | ▼ € 161,631 |
| Total debts | € 2,189,162 | € 2,400,958 | ▲ 10% |
| Cash | € 10,165 | € 12,432 | ▲ 22% |
| Retained profit | € -14,624 | € -176,255 | ▼ € 161,631 |
| Balance sheet total | € 2,184,537 | € 2,234,702 | ▲ 2% |
Key figures of VETAPHARMA BELGIUM, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VETAPHARMA BELGIUM?
What happened at VETAPHARMA BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 161,631. filed late Source: NBB ↗
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 14,624 loss in 2024 to € 161,631 loss in 2025.
Management
Behind VETAPHARMA BELGIUM is David Beciani. The shares are held by VETASERVICES. It owns 82% of GVéTéS itself.
Directors
According to the 2025 annual accounts
David Beciani
Director
Shareholders
Participations
82%
Establishments
Establishment units
Physical locations of this company
Rue Pont-à-Migneloux 39
6041 Charleroi
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0799.278.713
- VAT number
- BE 0799.278.713
- Registered office
- Rue Pont-à-Migneloux 39, 6041 Charleroi
- Names & denominations
- VETAPHARMA BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 March 2023
- Peppol
- Active · Active since 17 Feb 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Speur- en ontwikkelingswerk op biotechnologisch gebied